Injective Launches Onchain Pre-IPO Markets

Today, Injective is redefining the future of global markets by launching the world's first Pre-IPO perpetual futures markets.

This never-before-seen development brings the massive $2+ trillion Pre-IPO market directly onchain, enabling anyone to trade exposure to major private companies like OpenAI, SpaceX, Anthropic, and Perplexity with up to 5x leverage.

Breaking Down Traditional Finance Barriers

One of Injective's core visions has always been to make finance more accessible to everyone, everywhere. Today, that vision expands greatly as Injective becomes one of the first players to launch onchain private company stock derivatives for the $2+ trillion pre-ipo equity market. This development delivers on Injective's commitment to financial democratization by bringing private company equity onchain for the first time in an easy-to-trade format. Major applications on Injective such as Helix will be bringing these markets to users worldwide starting with assets such as OpenAI.

Beyond expanding access, Injective’s model challenges the legacy notion that control over valuable assets should remain limited to institutions. True democratization means enabling both participation and shared upside, ensuring that opportunity is defined by merit and contribution rather than gatekeeping.

Traditional barriers to invest in private companies:

Regulatory restrictions limiting access to accredited investors (at least $1M net worth or $200,000 in income)
High investment minimums often exceeding $1 million
Long lockup periods restricting liquidity
Complex compliance processes across multiple jurisdictions

These restrictions have left 87% of global companies that remain private largely inaccessible to everyday investors, despite the undisputed innovation, capital formation, and value creation happening in private markets.

Even when access exists, affordability and liquidity remain barriers. Traditional structures often impose hidden fees, custodial overhead, or jurisdictional constraints that discourage true inclusion. Injective’s onchain architecture reduces these frictions by design.

The Pre-IPO Market: A $2+ Trillion Opportunity

The pre-IPO landscape represents one of the most lucrative yet inaccessible segments of global finance. Global private equity deal values rose to $495 billion in Q1 2025, representing a near 40% jump from the previous year. The broader global private markets are estimated to grow from $13 trillion today to more than $20 trillion by 2030, highlighting the massive scale of opportunities previously unavailable to most investors.

Recent performance data underscores the attractiveness of private markets. Caplight's Top 20 Index returned +72% in 2024, significantly outperforming the Nasdaq-100 (+26%) and Renaissance IPO ETF (+17%). Top performers included Revolut (+281%), SpaceX (+111%), and Stripe (+70%), demonstrating the exceptional growth potential within Pre-IPO markets.

Until now, these growth curves primarily rewarded insiders. Injective’s onchain design allows the broader community to engage transparently, leveling access to asset classes once reserved for the few.

Trading the Hottest Private Company Names

Injective's Pre-IPO perpetual futures provide access to some of the most sought-after private companies across multiple high-growth sectors. Using data provided exclusively by Caplight and SEDA, Injective is breaking ground on an entirely new asset class.

These companies represent the most valuable private startups in sectors experiencing explosive growth, particularly in data & AI, which raised over $100 billion in 2024. Combined, 7 tech startups in that sector recently reached a combined $1.3 trillion valuation, with OpenAI leading the private market surge.

By tokenizing exposure and enabling composability across DeFi, Injective ensures that these assets become programmable and globally distributed without legacy intermediaries.

The Future of Onchain Finance

Injective's Pre-IPO perpetual futures represent the next evolution in decentralized finance, combining the massive $2+ trillion private company equity market with the accessibility and transparency of crypto.

As the Pre-IPO market continues its rapid expansion and institutional adoption of crypto derivatives accelerates, Injective's pioneering approach positions the platform at the forefront of financial innovation. This launch delivers on Injective's core mission to make sophisticated financial instruments accessible to everyone, everywhere, while maintaining the security and transparency that only crypto can provide.

About Injective

Injective is a lightning fast interoperable layer one blockchain optimized for building premier Web3 finance applications. Injective provides developers with powerful plug-and-play modules for creating unmatched dApps. INJ is the native asset that powers Injective and its rapidly growing ecosystem. Injective is incubated by Binance and is backed by prominent investors such as Jump Crypto, Pantera and Mark Cuban.